Ernest Pharmaceuticals LLC was founded in 2016 by Dr. Neil Forbes and Dr. Nele Van Dessel at the University of Massachusetts at Amherst. Ernest Pharmaceuticals seeks to create a novel bacterial platform that revolutionizes cancer treatment success through innovations in intracellular macromolecule delivery.